1Beckman J A, Creager M A, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management[J]. JAMA,2002,287(19) :2570-2581.
2Ridker P M, Cushman M, Stampfer M J, et al. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease [J]. Circulation, 1998, 97 ( 5 ):425- 428.
3Veves A, Akbari C M, Primavera J, et al. Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration[J]. Diabetes, 1998,47(3): 457-463.
4Steinberg H O, Baron A D. Vascular function, insulin resistance and fatty acids[J]. Diabetologia, 2002,45 (5) : 623-634.
5Geng Y J, Libby P. Progression of atheroma: a struggle between death and procreation[J]. Arterioseler Thromb Vasc Bioi,2002, 22(9) : 1370-1380.
6Tsao P S, Wang B, Buitrago R, et al. Nitric oxide regulates monocyte chemotactic protein-1 [J]. Circulation, 1997, 96 (3) : 934-940.
7Howard B V, Magee M F. Diabetes and cardiovascular disease [J]. Curr Atheroscler Rep,2000,2(6) :476-481.
8American Diabetes Association. Peripheral arterial disease in people with diabetes [J]. Diabetes Care, 2003, 26 (12) : 3333- 3341.
10Mutirangura P, Ruangsetakit C, Wongwanit C, et al. Comparative study of the management of diabetic versus nondiabetic patients with atherosclerosis obliterans of the lower extremities [J]. Vascular, 2008,16(6):333-9.
